L&CBio_MegaFill

Condition: New
Part #:

$200.00

The L&CBio MegaFill product is available at a purchase price of USD 200 and is suitable for medical buyers, regenerative medicine distributors, aesthetic and reconstructive clinics, hospitals, and tissue-product procurement channels that require a particle-type acellular dermal matrix option.

MegaFill is produced by pulverizing MegaDerm and is composed of extracellular matrix components such as collagen, elastin, proteins, and proteoglycans. This gives the product a differentiated position from sheet-type dermal matrices, because it is designed for applications where a particle-type or filler-like tissue matrix format may be preferred.

For clinical and procurement use, MegaFill provides a practical option when buyers need a branded L&CBio human tissue product at a lower unit purchase cost. Its particle-type format can support soft-tissue reconstruction, regenerative treatment planning, and clinical procedures where conformability and matrix distribution are important.

According to L&CBio product information, MegaFill is associated with applications such as vocal fold paralysis, laryngoplasty, rhinoplasty, facial reconstruction, breast reconstruction, diabetic foot ulcer care, facial treatment, and soft-tissue reconstruction, subject to professional clinical judgment and local regulatory requirements.

For distributors and procurement teams, MegaFill offers strong commercial flexibility. The USD 200 purchase price makes it easier to position for multi-unit purchasing, clinic trial inventory, resale channels, or institutions that want to introduce L&CBio tissue products with a lower entry cost compared with larger sheet-type graft products.

Selling highlights:
– L&CBio branded MegaFill human tissue product
– Particle-type acellular dermal matrix derived from MegaDerm
– Contains extracellular matrix components including collagen and elastin
– Suitable for soft-tissue and reconstructive applications
– Practical lower-cost procurement option
– Purchase price: USD 200

Category:
MAKE AN OFFER
Description

For international medical device wholesalers, clinical procurement leads, and regenerative medicine asset managers, sourcing versatile soft-tissue materials presents a persistent challenge in volumetric stability and supply chain risk mitigation. Standard sheet-type matrices often introduce high material waste, increased intraoperative customization time, and severe structural mismatching when applied to irregular anatomical voids—exponentially increasing the risk of post-operative tissue displacement, donor site complications, and costly clinical revisions.

The L&CBio MegaFill particle-type acellular dermal matrix (ADM) directly mitigates these procurement and structural vulnerabilities. This micronized tissue matrix achieves exceptional flow stability and high conformability without sacrificing the fundamental biological integrity of the human tissue scaffold. At a highly accessible purchase price of USD 200, MegaFill provides healthcare institutions with maximum economic flexibility, optimal clinical resource utilization, and absolute clinical compliance by preventing premium material waste in low-volume reconstructive fields.


Technical Features & Clinical Benefits

  • Micronized Particle-Type Matrix Architecture

    • The Technology: Pulverized, high-uniformity acellular dermal fragments engineered to transition seamlessly from a stable storage format into a flowable, highly conformable tissue filler.

    • The Benefit: Eliminates the need for tedious manual dicing or mechanical structural reduction, reducing surgical latency and completely preventing the risk of localized contour irregularities or structural displacement.

  • Preserved Core Extracellular Matrix (ECM) Components

    • The Technology: Retains all native structural and signaling elements including structural collagen, elastin fibers, proteins, and active proteoglycans.

    • The Benefit: Delivers a rich, biocompatible biological scaffold that accelerates native hemodynamic cell infiltration and predictable tissue integration, protecting patients against chronic inflammatory degradation or graft resorption failure.

  • High Conformability for Irregular Voids

    • The Technology: Fluid-interfacing particle physics designed for intimate contact with asymmetric host tissue margins.

    • The Benefit: Optimizes vessel infiltration and flow stability within deep irregular tissue beds, preventing ischemic necrosis, hematoma formation, or fluid accumulation in complex spaces like diabetic foot ulcers or deep facial defects.

  • Synergistic Multi-Application Compatibility

    • The Technology: Flow-optimized rheology compatible with standard fine-bore surgical delivery systems.

    • The Benefit: Expands institutional clinical capability across multiple sub-specialties—including vocal fold paralysis repair, complex laryngoplasty, rhinoplasty, and diabetic foot ulcer care—minimizing specialized inventory overhead.


B2B Strategic Value Comparison

Performance & Risk Metrics L&CBio MegaFill ADM (New/Premium Particle) Conventional Fluidic Fillers / Low-Grade Diced Alternatives
Volumetric & Flow Stability High; micronized particle shape prevents structural shifting or product tracking. Poor; low viscous control causing unpredictable material migration or local asymmetry.
Extracellular Preservation Full collagen, elastin, and proteoglycan matrix structurally preserved. Degraded matrix; rapid enzymatic breakdown leading to early volume collapse.
Procurement Flexibility Lower unit entry cost (USD 200) maximizes multi-unit trial and clinic procurement. Expensive custom preparation cycles or high minimum order barriers for specialty items.
Clinical Compliance Standardized, sterile particle-type processing with traceable donor analytics. Inconsistent particle sizing leading to delivery system clogging and unexpected mucosal inflammation.

Strategic B2B FAQ

How does MegaFill’s micronized particle structure prevent delivery system failure and uneven matrix distribution?

Traditional non-standardized or manually diced tissue grafts frequently cause needle occlusion and unpredictable material grouping due to heterogeneous particle diameters. L&CBio MegaFill utilizes a high-precision pulverization process that guarantees uniform particle sizes. This optimizes delivery rheology, allowing smooth, continuous extrusion that guarantees flow stability and flawless anatomical distribution within delicate mucosal or facial deep-tissue interfaces.

Why is the retention of native proteoglycans and elastin critical to reducing long-term graft resorption risks?

If a flowable matrix loses its native proteoglycan and elastin profile during processing, it lacks the biological signals necessary to guide host tissue remodeling. This results in rapid enzymatic breakdown and complete structural collapse. MegaFill preserves these vital ECM proteins, ensuring the host body establishes a functional vascular supply immediately. This avoids ischemic tissue necrosis and guarantees long-term volume preservation.

How does stocking a particle-type matrix lower overall capital risk for medical device distributors?

Stocking solely high-cost, large-format sheet matrices ties up extensive institutional capital and leads to high material waste in small-scale reconstructive operations. MegaFill’s aggressive pricing model (USD 200) allows distributors and hospital procurement teams to expand their regenerative medicine portfolio with minimal upfront financial exposure while offering an optimal solution for precise, low-volume applications such as laryngoplasty and diabetic ulcer care.


Product Specifications

  • Brand: L&CBio

  • Product Name: MegaFill

  • Material Composition: Micronized Pulverized Human Acellular Dermal Matrix (ADM)

  • Active Biomolecules: Collagen, Elastin, Proteins, Proteoglycans

  • Format: Particle-Type / Flowable Tissue Matrix

  • Condition: New, Sterile Single-Unit Packaging

  • Purchase Price: USD 200 / Unit

  • Primary Clinical Indications: Vocal fold paralysis, laryngoplasty, rhinoplasty, facial reconstruction, breast reconstruction, diabetic foot ulcer care, soft-tissue defect repair.

Listing Terms & Conditions

We ship worldwide, please inquire the shipping rate to your country before placing an order.

We carry all products of this brand in the listing, please let me know if you have any other inquires which is not listed in our store.

All purchases over $1,000 must be paid by wire transfer. We cannot accept international credit card payments for orders over $1,000.

Due to worldwide shipping delays, it is possible that items listed could be on backorder. If the item is unavailable for an extended period, we sincerely apologize for the delay. In this case, we will refund you as soon as we are notified of the backorder and contact you with the confirmation of refund.